Bio

Mr. Ross has 8 years of private equity investing experience. Prior to joining NaviMed Capital, Mr. Ross was an Associate at Capitala Group, a provider of capital to lower and traditional middle-market companies through its family of funds. Throughout his career, he has supported the origination and execution of over 20 investments, including control equity, minority equity, and subordinated debt from issuers across several industries, in transactions such as leveraged buyouts, management buyouts, add-on acquisitions, and growth financings. Mr. Ross has worked on transactions in healthcare providers, payor services, medical products, and outsourced pharma services, among others. Mr. Ross currently serves on the Board of Directors for Elite Diagnostics, The CM Group, Velocity Clinical Research and is a Board Observer for CenterPointe Behavioral Health System and OPN Healthcare. Mr. Ross holds a BS in Finance from East Carolina University and an MBA from the Wharton School, University of Pennsylvania.